Ulcerated tophaceous gout

International Wound Journal

Volumn 7, Issue 5, 2010, Pages 423-427

  Patel, Girish K ^a   Davies, Wendy L ^a   Price, Patricia P ^a   Harding, Keith G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gout; Ulcer

Indexed keywords

ALLOPURINOL; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; HYDROXYUREA; PROTEIN SLC17A3; PROTEIN SLC22A12; PROTEIN SLC2A9; UNCLASSIFIED DRUG; URIC ACID;

AGED; ARTICLE; CASE REPORT; COMORBIDITY; FEMALE; GENETIC POLYMORPHISM; GOUT; HUMAN; HYPERURICEMIA; MALE; METATARSOPHALANGEAL JOINT; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SKIN ULCER; TOPHACEOUS GOUT; URIC ACID BLOOD LEVEL;

AGED; AGED, 80 AND OVER; FEMALE; GOUT; HUMANS; HYDROGEL; MALE; SKIN ULCER; WOUND HEALING;

EID: 77956949587     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2010.00700.x     Document Type: Article

References (27)

1. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995 48 : 1153 8.
2. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008 67 : 960 6.
3. Doherty M. New insights into the epidemiology of gout. Rheumatology 2009 48 : 2 8.
4. Wallace K, Riedel A, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricaemia over 10 years among older adults in a managed care population. J Rheumatol 2004 31 : 1582 7.
5. Richette P, Bardin T. Gout. Lancet 2009 6737 : 60833 7.
6. De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. Elderly-onset gout: a review. Rheumatol Int 2007 28 : 1 6.
7. Schumacher Jr. HR, Becker MA, Palo WA, Streit J, MacDonald PA, Joseph-Ridge N. Topheaceous gout: quantitative evaluation by direct physical measurement. J Rheumatol 2005 32 : 2368 72.
8. Price P, Harding K. Cardiff wound impact schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chonic wounds of the lower limb. Int Wounds J 2004 1 : 10 7.
9. Choi HK, Artkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004 350 : 1093 103.
10. Brulé D, Sarwar G, Savoie L. Changes in serum and urinary uric acid levels in normal human subjects fed purine-rich foods containing different amounts of adenine and hypoxanthine. J Am Coll Nutr 1992 11 : 353 8.
11. Liebman SE, Taylor JG, Bushinsky DA. Uric acid nephrolithiasis. Curr Rheum Rep 2007 9 : 251 7.
12. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med 2005 143 : 499 516.
13. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002 417 : 447 52.
14. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, Knott SA, Kolcic I, Polasek O, Graessler J, Wilson JF, Marinaki A, Riches PL, Shu X, Janicijevic B, Smolej-Narancic N, Gorgoni B, Morgan J, Campbell S, Biloglav Z, Barac-Lauc L, Pericic M, Klaric IM, Zgaga L, Skaric-Juric T, Wild SH, Richardson WA, Hohenstein P, Kimber CH, Tenesa A, Donnelly LA, Fairbanks LD, Aringer M, McKeigue PM, Ralston SH, Morris AD, Rudan P, Hastie ND, Campbell H, Wright AF. SLC2A9 is a newly identified urate transporter influencing serum urate concetration, urate excretion and gout. Nat Genet 2008 40 : 437 42.
15. Stein R. The genetic basis of uric acid variance. Clin Genet 2008 74 : 410 3.
16. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associateed uric acid crystals activate the NALP3 inflammasome. Nature 2006 440 : 237 41.
17. Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, Li T, Lowell CA, Ling CC, Amrein MW, Shi Y. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 2008 29 : 807 18.
18. O'Duffy JD, Hunder GG, Kelly PJ. Decreasing prevalence of tophaceous gout. Mayo Clin Proc 1975 50 : 227 8.
19. Lawry GV, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine 1988 67 : 335 43.
20. Wernick R, Winkler C, Campbell S. Tophi as the initial presentation of gout. Arch Intern Med 1992 152 : 873 6.
21. Ter Borg EJ, Rasker JJ. Gout in the elderly, a separate entity? Ann Rheum Dis 1987 46 : 72 6.
22. Palmer DG, Highton J, Hessian PA. Development of the gout tophus. Am J Clin Pathol 1989 91 : 190 5.
23. Lucke TW, Fallowfield ME, Evans A et al. Transepidermal elimination of urate-like crystals: a new perforating disorder? Br J Dermatol 1999 141 : 310 4.
24. Choi HK, Artkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005 165 : 742 8.
25. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease death: the Framingham Heart Study. Ann Intern Med 1999 131 : 7 13.
26. Niskanen LK, Laaksonen DE, Nyyssonen K et al. Uric acid levels as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004 164 : 1546 51.
27. Rho YH, Choi SJ, Lee YH et al. The prevalence of metabolic syndrome in patients with gout: a multi center study. J Korean Med Sci 2005 20 : 1029 33.